WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Daniel Comas Biography and Net Worth

EVP of Danaher

Daniel L. Comas serves as Executive Vice President of the Company. He is no longer Chief Financial Officer of the Company eff. He served as Executive Vice President since January 2019, after serving as Executive Vice President and Chief Financial Officer from 2005 until December 2018.

What is Daniel L. Comas' net worth?: The estimated net worth of Daniel L. Comas is at least $29.69 million as of October 23rd, 2020. Mr. Comas owns 130,161 shares of Danaher stock worth more than $29,694,931 as of December 23rd. This net worth evaluation does not reflect any other investments that Mr. Comas may own. Learn More about Daniel L. Comas' net worth.
How do I contact Daniel L. Comas?: The corporate mailing address for Mr. Comas and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Daniel L. Comas' contact information.
Has Daniel L. Comas been buying or selling shares of Danaher?: Daniel L. Comas has not been actively trading shares of Danaher during the last quarter. Most recently, Daniel L. Comas sold 54,402 shares of the business's stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $233.25, for a transaction totalling $12,689,266.50. Following the completion of the sale, the executive vice president now directly owns 130,161 shares of the company's stock, valued at $30,360,053.25. Learn More on Daniel L. Comas' trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (President, CEO & Director), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 16 times. They sold a total of 221,399 shares worth more than $56,844,951.46. The most recent insider tranaction occured on August, 26th when SVP Georgeann Couchara sold 952 shares worth more than $255,488.24. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 8/26/2024.

Daniel L. Comas Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/23/2020	Sell	54,402	$233.25	$12,689,266.50	130,161
7/27/2020	Sell	100,032	$194.56	$19,462,225.92	134,933
7/24/2020	Sell	88,978	$193.97	$17,259,062.66	134,933
2/3/2020	Sell	3,100	$161.34	$500,154.00	121,242
1/31/2020	Sell	79,364	$161.50	$12,817,286.00	121,242
7/19/2019	Sell	68,379	$142.05	$9,713,236.95	187,474
5/16/2019	Sell	7,726	$132.41	$1,022,999.66	119,095
4/29/2019	Sell	30,000	$131.00	$3,930,000.00	164,039
2/27/2019	Sell	97,357	$127.04	$12,368,233.28	134,039
11/8/2018	Sell	36,000	$103.88	$3,739,680.00	124,218
7/26/2018	Sell	77,407	$103.93	$8,044,909.51	135,218
4/23/2018	Sell	78,379	$101.67	$7,968,792.93	148,769
4/20/2018	Sell	25,206	$101.39	$2,555,636.34	148,769
2/1/2018	Sell	62,989	$101.96	$6,422,358.44	227,805
10/23/2017	Sell	88,184	$91.02	$8,026,507.68	227,816
7/27/2016	Sell	96,446	$80.88	$7,800,552.48	215,716
4/22/2016	Sell	89,280	$95.71	$8,544,988.80	230,978
10/23/2015	Sell	36,200	$92.71	$3,356,102.00	99,798
4/24/2015	Sell	25,000	$83.50	$2,087,500.00
1/28/2015	Sell	75,000	$84.59	$6,344,250.00
10/24/2013	Sell	50,000	$71.65	$3,582,500.00
7/22/2013	Sell	54,540	$68.14	$3,716,355.60
5/21/2013	Sell	55,000	$63.89	$3,513,950.00

Daniel L. Comas Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $228.14

$226.76

$229.35

50 Day Range

MA: $243.07

$226.16

$274.33

2 Week Range

Now: $228.14

$222.53

$281.70

Volume

1,019,151 shs

Average Volume

2,820,309 shs

Market Capitalization

$164.78 billion

P/E Ratio

43.54

Dividend Yield

0.47%

Beta

0.83